Jeff Schaffnit Shares Sanofi’s Patient Advocacy Voices Series with Caroline Kruse
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared on LinkedIn:
”Many people living with immune thrombocytopenia (ITP) face a critical hurdle: getting a proper diagnosis.
Caroline Kruse, President and CEO of the Platelet Disorder Support Association – PDSA, and other experts know this challenge well.
Despite the organization’s over 25 years of educating, supporting and advocating for the ITP community, diagnosis remains one of the most critical unmet needs for people living with ITP and other rare blood disorders.
My colleague Eric Racine, PharmD, MBA had the opportunity to speak with Caroline as part of Sanofi’s Patient Advocacy Voices series.
We stand proudly with PDSA and the ITP community in our commitment to raising awareness and supporting people living with ITP.
Watch the full conversation here.”
Stay updated with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis